The U.S. International Trade Commission (ITC) has issued an import ban on certain skin treatment devices, finding that they infringe on patents held by the U.S. subsidiary of a South Korean dermatologist’s needle business. This decision underscores the ITC’s role in adjudicating complex international patent disputes and highlights ongoing patent enforcement efforts in the dermatological device industry.
The ruling is a significant development for companies involved in skin treatment products, as it restricts the importation of devices that contravene the established patents. This measure reflects the growing scrutiny and protection of intellectual property rights within the sector.
For further details, the original article is available on Law360.